🟢 Femasys is trading 5.7% up with no clear company-specific catalyst

Femasys is trading 5.74% higher at $2.21, with no clear company-specific announcement explaining the September 30 move.

• The latest located company news was the September 9 CapexMD partnership, not a new catalyst for this session.
• The Nasdaq is up 0.85% and the S&P 500 is up 0.52%, offering a possible risk-on backdrop; the available information does not establish that market strength caused the move.